CoChat

Ketamine and the Future of Rapid-Acting Antidepressants

Open access
Riggs, Lace M., Gould, Todd D. · 2021 · Annual Review of Clinical Psychology

The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.

Abstract

The therapeutic onset of traditional antidepressants is delayed by several weeks and many depressed patients fail to respond to treatment altogether. In contrast, subanesthetic ketamine can rapidly alleviate symptoms of depression within hours of a single administration, even in patients who are considered treatment-resistant. Ketamine is thought to exert these effects by restoring the integrity of neural circuits that are compromised in depression. This hypothesis stems in part from preclinical observations that ketamine can strengthen synaptic connections by increasing glutamate-mediated neurotransmission and promoting rapid neurotrophic factor release. An improved understanding of how ketamine, and other novel rapid-acting antidepressants, give rise to these processes will help foster future therapeutic innovation. Here, we review the history of antidepressant treatment advances that preceded the ketamine discovery, critically examine mechanistic hypotheses for how ketamine may exert its antidepressant effects, and discuss the impact this knowledge has had on ongoing drug discovery efforts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-clinpsy-072120-014126

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 144 references

Research works printed but not linked: 18

  1. Aguilar-Valles A, 2020, Nature
  2. Chaturvedi HK, 1999, Indian J. Pharmacol., 31, 104
  3. Crane GE., 1957, Psychiatr. Res. Rep. Am. Psychiatr. Assoc., 8, 142
  4. Delgado PL., 2000, J. Clin. Psychiatry, 61, 7
  5. Demyttenaere K, 2001, J. Clin. Psychiatry, 62, 30
  6. Hirschfeld RM., 2000, J. Clin. Psychiatry, 61, 4
  7. Lodge D, 1983, Phencyclidine and Related Arylcyclohexylamines: Present and Future Applications, 595
  8. Loomer HP, 1957, Psychiatr. Res. Rep. Am. Psychiatr. Assoc., 8, 129
  9. Mealing G, 1999, J. Pharmacol. Exp. Ther., 288, 204
  10. Molloy BB, 1994, Pharm. News, 1, 6
  11. Porsolt RD, 1977, Arch. Int. Pharmacodyn. Ther., 229, 327
  12. Smith JA., 1953, Am. Pract. Dig. Treat., 4, 519
  13. Sofia RD, 1975, Arch. Int. Pharmacodyn. Ther., 214, 68
  14. Stitzel RE., 1976, Pharmacol. Rev., 28, 179
  15. Trevino K, 2014, Ann. Clin. Psychiatry, 26, 222
  16. Udenfriend S, 1957, J. Pharmacol. Exp. Ther., 120, 255
  17. WHO (World Health Organ.), 2017, Depression and Other Common Mental Disorders: Global Health Estimates
  18. Zeller EA, 1955, Biochem. J., 60, v

Cited by

See all 87

Metadata

Authors
Riggs, L. M., & Gould, T. D.
Affiliations
University of Maryland, Baltimore (US)
Venue
Annual Review of Clinical Psychology
Published
2021-05-07
Volume
17
Issue
1
Pages
207-231
ISSN
  • 1548-5943 (ISSN-L)
  • 1548-5951
OpenAlex
W3128979569
Cited by
87
References
144
Citations by year
2026: 13 · 2025: 16 · 2024: 20 · 2023: 22 · 2022: 10 · 2021: 6
FWCI
1.84
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Clinical Psychology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01BX004062, I01 BX003631)
  • National Institutes of Health (5f31mh123066-02, 2t32ns063391-21)
  • National Institute of Mental Health (F31-MH123066, R01MH107615)
  • National Institute of General Medical Sciences (T32GM008181, R25GM055036)
  • National Institute of Allergy and Infectious Diseases (R21AI145211)
  • National Institute of Neurological Disorders and Stroke (T32-NS063391)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
ketamine, rapid-acting antidepressants, depression, treatment-resistant depression, glutamatergic neurotransmission, synaptic plasticity, neurotrophic factors, antidepressant drug discovery
MeSH terms
Antidepressive Agents, Humans, Ketamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine and the Future of Rapid-Acting Antidepressants. https://app.cochat.ai/papers/10.1146/annurev-clinpsy-072120-014126
The paper
Riggs, L. M., & Gould, T. D. (2021). Ketamine and the Future of Rapid-Acting Antidepressants. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev-clinpsy-072120-014126

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.